Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Aluminium oxide- and magnesium hydroxide- and oxetacaine-containing product |
Is a |
Aluminium oxide-containing product |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aluminium oxide- and magnesium hydroxide- and oxetacaine-containing product |
Is a |
Magnesium hydroxide (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aluminium oxide- and magnesium hydroxide- and oxetacaine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Magnesium hydroxide |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Aluminium oxide- and magnesium hydroxide- and oxetacaine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Topical abrasive agent |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aluminium oxide- and magnesium hydroxide- and oxetacaine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Magnesium |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aluminium oxide- and magnesium hydroxide- and oxetacaine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Magnesium-based antacid |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aluminium oxide- and magnesium hydroxide- and oxetacaine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Laxative |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aluminium oxide- and magnesium hydroxide- and oxetacaine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Trace element supplementation |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aluminium oxide- and magnesium hydroxide- and oxetacaine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Aluminium oxide (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Aluminium oxide- and magnesium hydroxide- and oxetacaine-containing product |
Is a |
Oxetacaine-containing product |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aluminium oxide- and magnesium hydroxide- and oxetacaine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Oxetacaine |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|